Opus Point Partners Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-120,000
| Closed | -$4.16M | – | 51 |
|
|
2017
Q4 | $4.16M | Hold |
120,000
| – | – | 3.6% | 8 |
|
|
2017
Q3 | $4.07M | Hold |
120,000
| – | – | 3.65% | 7 |
|
|
2017
Q2 | $4.09M | Hold |
120,000
| – | – | 3.75% | 5 |
|
|
2017
Q1 | $3.74M | Hold |
120,000
| – | – | 2.77% | 12 |
|
|
2016
Q4 | $3.28M | Hold |
120,000
| – | – | 2.61% | 12 |
|
|
2016
Q3 | $3.94M | Buy |
120,000
+11,437
| +11% | +$376K | 2.21% | 6 |
|
|
2016
Q2 | $3.28M | Buy |
108,563
+29,463
| +37% | +$890K | 3.17% | 7 |
|
|
2016
Q1 | $2.23M | Buy |
79,100
+30,000
| +61% | +$845K | 1.72% | 23 |
|
|
2015
Q4 | $1.67M | Sell |
49,100
-86,900
| -64% | -$2.95M | 1.1% | 28 |
|
|
2015
Q3 | $4.33M | Buy |
136,000
+36,000
| +36% | +$1.15M | 2.39% | 15 |
|
|
2015
Q2 | $3.19M | Buy |
+100,000
| New | +$3.19M | 2.52% | 23 |
|